News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Enzon Pharmaceuticals, Inc. (ENZN) Shareholder Opposes Biotech Business Spin-off



11/26/2008 6:14:14 AM

Nov 26 (Reuters) - Enzon Pharmaceuticals Inc's shareholder DellaCamera Capital said it was opposed to the spin-off of the company's biotechnology business.

Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES